SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for GDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 107.87M
December 31, 2025 102.55M
September 30, 2025 115.55M
June 30, 2025 113.25M
March 31, 2025 114.17M
December 31, 2024 117.38M
September 30, 2024 115.49M
June 30, 2024 121.04M
March 31, 2024 131.07M
December 31, 2023 124.12M
September 30, 2023 126.93M
June 30, 2023 107.65M
March 31, 2023 108.14M
December 31, 2022 112.71M
September 30, 2022 135.76M
Date Value
June 30, 2022 129.08M
March 31, 2022 124.87M
December 31, 2021 141.86M
September 30, 2021 131.60M
June 30, 2021 127.96M
March 31, 2021 123.48M
December 31, 2020 415.69M
September 30, 2020 173.59M
June 30, 2020 58.25M
March 31, 2020 69.05M
December 31, 2019 58.86M
September 30, 2019 49.05M
June 30, 2019 41.20M
March 31, 2019 42.55M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
SCWorx Corp. 0.2102M
Health Catalyst, Inc. 24.54M
Claritev Corp. 57.83M
iSpecimen, Inc. 2.223M
Definitive Healthcare Corp. 31.66M